Who
Mallory Morales
SVP Finance, CAO
Company insider
Files Form 4 as: SVP Finance, CAO, Immuneering.
In numbers
- Trades disclosed
- 25
- Buys
- 3
- Sells
- 0
- Bought
- $5,930
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 11 Aug 2022
- Last trade
- 3 Feb 2026
- Last filed
- 5 Feb 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Feb 2026filed 5 Feb 2026 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —140,000 at $0.00 | filing |
| 3 Feb 2026filed 5 Feb 2026 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —140,000 at $0.00 | filing |
| 1 Oct 2025filed 2 Oct 2025 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $1,917300 at $6.39 | filing |
| 15 Sep 2025filed 17 Sep 2025 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Code A | $21K14,497 at $1.43 | filing |
| 5 Feb 2025filed 7 Feb 2025 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —110,000 at $0.00 | filing |
| 15 Sep 2024filed 17 Sep 2024 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Code A | $7,2224,458 at $1.62 | filing |
| 21 May 2024filed 23 May 2024 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code D | —10,000 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code D | —23,850 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —23,850 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code D | —5,000 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,000 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code D | —15,000 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code D | —60,500 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,500 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code D | —72,000 at $0.00 | filing |
| 21 May 2024filed 23 May 2024 | IMRX Immuneeringoption or derivative · Biotechnology | SEC FORM 4 Code A | —72,000 at $0.00 | filing |
| 22 Mar 2024filed 25 Mar 2024 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $1,002393 at $2.55 | filing |
| 21 Mar 2024filed 25 Mar 2024 | IMRX ImmuneeringBiotechnology | SEC FORM 4 Bought | $3,0111,107 at $2.72 | filing |
News
No headline names them, or the companies they trade most, lately.